HOME
RESOURCES
MEMBERS
EVENTS
PATIENTS
NEWS
ABOUT
Overview
Quality Initiatives
Join
Health Equity
Team
Contact Us
Event Recordings
Publications
Patient Data Dashboard
SPECIALTY CARE
Nephrology
MY RESOURCES
Point of Care Tools
My Bookmarks
Coverage Checker
ADMIN PORTAL
PATIENT DATA DASHBOARD
NEWS

ABOUT

OverviewQuality InitiativesJoinHealth EquityTeamContact UsEvent RecordingsPublicationsPatient Data Dashboard

SPECIALTY CARE

Nephrology

MY RESOURCES

Point of Care ToolsMy BookmarksCoverage Checker
ADMIN PORTAL
PATIENT DATA DASHBOARD
MCT2D Logo
RESOURCESMEMBERSEVENTSPATIENTS
Search Icon

Learning Community: Medications Quality Improvement Panel

Updated: 07/23/24

Watch the Recorded Talk
June 28, 2024 12:00 PM
A panel of MCT2D members across the state shared insights on practice- and PO-level quality improvement progress in prescribing SGLT2i and GLP-1 RA for type 2 diabetes.
Panelists included:
Rebecca Vermaat, AAS, CMA (AAMA), Performance Improvement Specialist, Answer Health
Kim Miazek, RN, Registered Nurse Supervisor, Henry Ford Health System 
Nadia Aneese, PharmD, Robert Vartabedian, MD, Livingston Physician Organization 
Lindsey Klynstra, RN, Manager, Value-Based Care Operations, Huron Valley Physician Association
Our panelists responded to a variety of questions, including:
  1. Explain the goal your PO had around medications, the process changes you made, and if they have been successful.
  2. What worked well for you in trying to make these changes?
  3. What was harder than expected?
  4. There can be competing thoughts on how things should be addressed and accomplished. What barriers of opinion did you face? How did you achieve consensus/buy-in?
  5. What is your biggest takeaway from the process?
  6. What changes is your practice planning to implement next?
  7. What is needed from a policy perspective to reduce “friction” & make it easier for your practice to operationalize guideline directed medication prescribing?
  8. What one thing would you like MCT2D to do to help you achieve your goals with regard to guideline directed medication prescribing for patients with T2D?

Tags: Created By MCT2D, Video, For Providers, VBR Learning

MCT2D Newsletter

Subscribe to the MCT2D Newsletter

Once per month we deliver news, updates, events, and more directly to you!

ccteam@mct2d.org

ResourcesPoint of CareMy BookmarksMembersEventsNewsPatientsSpecialty CareNephrology
AboutOverviewQuality InitiativesJoinHealth EquityTeam
A nonprofit and independent licensee of the Blue Cross Blue Shield Association

Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program.

Although Blue Cross Blue Shield of Michigan and MCT2D work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.